Regulation & law · 06/10/1999
Pettigrew Rexall Drugs Reinstatement of Registration
The U.S. Food and Drug Administration (FDA) has reinstated the registration of Pettigrew Rexall Drugs, a pharmaceutical company, following a successful review process.
Original source language: Federal Register — All DocumentsOpen original release →